{
  "DOI": "10.1016/j.ajhg.2007.10.002",
  "ISSN": [
    "0002-9297"
  ],
  "URL": "http://dx.doi.org/10.1016/j.ajhg.2007.10.002",
  "alternative-id": [
    "S0002929708000736"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Scott",
      "given": "Stuart A.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Edelmann",
      "given": "Lisa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kornreich",
      "given": "Ruth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Desnick",
      "given": "Robert J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "The American Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2008,
        1,
        22
      ]
    ],
    "date-time": "2008-01-22T14:40:51Z",
    "timestamp": 1201012851000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        16
      ]
    ],
    "date-time": "2023-05-16T00:52:25Z",
    "timestamp": 1684198345000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        15
      ]
    ],
    "date-time": "2023-11-15T00:02:06Z",
    "timestamp": 1700006526525
  },
  "is-referenced-by-count": 106,
  "issn-type": [
    {
      "type": "print",
      "value": "0002-9297"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2008,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2008,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2008,
            2,
            1
          ]
        ],
        "date-time": "2008-02-01T00:00:00Z",
        "timestamp": 1201824000000
      }
    },
    {
      "URL": "https://www.elsevier.com/open-access/userlicense/1.0/",
      "content-version": "vor",
      "delay-in-days": 1995,
      "start": {
        "date-parts": [
          [
            2013,
            7,
            19
          ]
        ],
        "date-time": "2013-07-19T00:00:00Z",
        "timestamp": 1374192000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929708000736?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929708000736?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "member": "78",
  "page": "495-500",
  "prefix": "10.1016",
  "published": {
    "date-parts": [
      [
        2008,
        2
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        2
      ]
    ]
  },
  "publisher": "Elsevier BV",
  "reference": [
    {
      "article-title": "Racial and ethnic differences in warfarin response",
      "author": "El Rouby",
      "first-page": "15",
      "journal-title": "J. Heart Valve Dis.",
      "key": "10.1016/j.ajhg.2007.10.002_bib1",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1097/01.moh.0000239708.70792.4f",
      "article-title": "Genetic influences on the response to warfarin",
      "author": "Kamali",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "journal-title": "Curr. Opin. Hematol.",
      "key": "10.1016/j.ajhg.2007.10.002_bib2",
      "volume": "13",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.0902-4441.2006.t01-1-EJH2957.x",
      "article-title": "Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: The need for a more tailored dosing regimen",
      "author": "Sconce",
      "doi-asserted-by": "crossref",
      "first-page": "457",
      "journal-title": "Eur. J. Haematol.",
      "key": "10.1016/j.ajhg.2007.10.002_bib3",
      "volume": "77",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.tpj.6500417",
      "article-title": "Pharmacogenetics of warfarin: Current status and future challenges",
      "author": "Wadelius",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Pharmacogenomics J.",
      "key": "10.1016/j.ajhg.2007.10.002_bib4",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s11239-006-9030-7",
      "article-title": "Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: A prospective study",
      "author": "Carlquist",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "journal-title": "J. Thromb. Thrombolysis",
      "key": "10.1016/j.ajhg.2007.10.002_bib5",
      "volume": "22",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.thromres.2006.10.021",
      "article-title": "Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - Rationale and perspectives",
      "author": "Yin",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Thromb. Res.",
      "key": "10.1016/j.ajhg.2007.10.002_bib6",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.1373/clinchem.2006.078139",
      "article-title": "Estimation of warfarin maintenance dose based on VKORC1 (−1639 G→A) and CYP2C9 genotypes",
      "author": "Zhu",
      "doi-asserted-by": "crossref",
      "first-page": "1199",
      "journal-title": "Clin. Chem.",
      "key": "10.1016/j.ajhg.2007.10.002_bib7",
      "volume": "53",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.clpt.2006.06.009",
      "article-title": "A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9",
      "author": "Tham",
      "doi-asserted-by": "crossref",
      "first-page": "346",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2007.10.002_bib8",
      "volume": "80",
      "year": "2006"
    },
    {
      "DOI": "10.1182/blood-2005-03-1108",
      "article-title": "The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen",
      "author": "Sconce",
      "doi-asserted-by": "crossref",
      "first-page": "2329",
      "journal-title": "Blood",
      "key": "10.1016/j.ajhg.2007.10.002_bib9",
      "volume": "106",
      "year": "2005"
    },
    {
      "DOI": "10.1093/hmg/ddi180",
      "article-title": "A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity",
      "author": "Yuan",
      "doi-asserted-by": "crossref",
      "first-page": "1745",
      "journal-title": "Hum. Mol. Genet.",
      "key": "10.1016/j.ajhg.2007.10.002_bib10",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.clpt.2004.08.009",
      "article-title": "Clinical consequences of cytochrome P450 2C9 polymorphisms",
      "author": "Kirchheiner",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2007.10.002_bib11",
      "volume": "77",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nature02254",
      "article-title": "Identification of the gene for vitamin K epoxide reductase",
      "author": "Li",
      "doi-asserted-by": "crossref",
      "first-page": "541",
      "journal-title": "Nature",
      "key": "10.1016/j.ajhg.2007.10.002_bib12",
      "volume": "427",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nature02214",
      "article-title": "Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2",
      "author": "Rost",
      "doi-asserted-by": "crossref",
      "first-page": "537",
      "journal-title": "Nature",
      "key": "10.1016/j.ajhg.2007.10.002_bib13",
      "volume": "427",
      "year": "2004"
    },
    {
      "DOI": "10.1160/TH04-08-0540",
      "article-title": "Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1",
      "author": "Harrington",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "journal-title": "Thromb. Haemost.",
      "key": "10.1016/j.ajhg.2007.10.002_bib14",
      "volume": "93",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1538-7836.2006.02261.x",
      "article-title": "A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme",
      "author": "D'Ambrosio",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "journal-title": "J. Thromb. Haemost.",
      "key": "10.1016/j.ajhg.2007.10.002_bib15",
      "volume": "5",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1538-7836.2005.01449.x",
      "article-title": "A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance",
      "author": "Bodin",
      "doi-asserted-by": "crossref",
      "first-page": "1533",
      "journal-title": "J. Thromb. Haemost.",
      "key": "10.1016/j.ajhg.2007.10.002_bib16",
      "volume": "3",
      "year": "2005"
    },
    {
      "DOI": "10.1182/blood-2006-08-038984",
      "article-title": "A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance",
      "author": "Loebstein",
      "doi-asserted-by": "crossref",
      "first-page": "2477",
      "journal-title": "Blood",
      "key": "10.1016/j.ajhg.2007.10.002_bib17",
      "volume": "109",
      "year": "2007"
    },
    {
      "DOI": "10.2217/14622416.8.7.721",
      "article-title": "CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population",
      "author": "Scott",
      "doi-asserted-by": "crossref",
      "first-page": "721",
      "journal-title": "Pharmacogenomics",
      "key": "10.1016/j.ajhg.2007.10.002_bib18",
      "volume": "8",
      "year": "2007"
    },
    {
      "article-title": "The human cytochrome P450 Allele Nomenclature Committee Web site: Submission criteria, procedures, and objectives",
      "author": "Sim",
      "first-page": "183",
      "journal-title": "Methods Mol. Biol.",
      "key": "10.1016/j.ajhg.2007.10.002_bib19",
      "volume": "320",
      "year": "2006"
    },
    {
      "DOI": "10.1046/j.1365-2362.33.s2.6.x",
      "article-title": "Clinical relevance of genetic polymorphisms in the human CYP2C9 gene",
      "author": "Schwarz",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "issue": "Suppl 2",
      "journal-title": "Eur. J. Clin. Invest.",
      "key": "10.1016/j.ajhg.2007.10.002_bib20",
      "volume": "33",
      "year": "2003"
    },
    {
      "DOI": "10.1097/00008571-200204000-00010",
      "article-title": "Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data",
      "author": "Lee",
      "doi-asserted-by": "crossref",
      "first-page": "251",
      "journal-title": "Pharmacogenetics",
      "key": "10.1016/j.ajhg.2007.10.002_bib21",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0169-409X(02)00076-5",
      "article-title": "CYP2C9 allelic variants: Ethnic distribution and functional significance",
      "author": "Xie",
      "doi-asserted-by": "crossref",
      "first-page": "1257",
      "journal-title": "Adv. Drug Deliv. Rev.",
      "key": "10.1016/j.ajhg.2007.10.002_bib22",
      "volume": "54",
      "year": "2002"
    },
    {
      "DOI": "10.1160/TH03-12-0741",
      "article-title": "The risk of bleeding complications in patients with cytochrome P450 CYP2C9∗2 or CYP2C9∗3 alleles on acenocoumarol or phenprocoumon",
      "author": "Visser",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "Thromb. Haemost.",
      "key": "10.1016/j.ajhg.2007.10.002_bib23",
      "volume": "92",
      "year": "2004"
    },
    {
      "DOI": "10.1001/jama.287.13.1690",
      "article-title": "Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy",
      "author": "Higashi",
      "doi-asserted-by": "crossref",
      "first-page": "1690",
      "journal-title": "JAMA",
      "key": "10.1016/j.ajhg.2007.10.002_bib24",
      "volume": "287",
      "year": "2002"
    },
    {
      "DOI": "10.1182/blood-2004-06-2111",
      "article-title": "A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin",
      "author": "D'Andrea",
      "doi-asserted-by": "crossref",
      "first-page": "645",
      "journal-title": "Blood",
      "key": "10.1016/j.ajhg.2007.10.002_bib25",
      "volume": "105",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMoa044503",
      "article-title": "Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose",
      "author": "Rieder",
      "doi-asserted-by": "crossref",
      "first-page": "2285",
      "journal-title": "N. Engl. J. Med.",
      "key": "10.1016/j.ajhg.2007.10.002_bib26",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1160/TH05-04-0290",
      "article-title": "VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation",
      "author": "Geisen",
      "doi-asserted-by": "crossref",
      "first-page": "773",
      "journal-title": "Thromb. Haemost.",
      "key": "10.1016/j.ajhg.2007.10.002_bib27",
      "volume": "94",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1538-7836.2006.02039.x",
      "article-title": "Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: A retrospective analysis of case records",
      "author": "Osman",
      "doi-asserted-by": "crossref",
      "first-page": "1723",
      "journal-title": "J. Thromb. Haemost.",
      "key": "10.1016/j.ajhg.2007.10.002_bib28",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1182/asheducation-2006.1.467",
      "article-title": "Pharmacogenetics-based coumarin therapy",
      "author": "Gage",
      "doi-asserted-by": "crossref",
      "first-page": "467",
      "journal-title": "Hematology (Am Soc Hematol Educ Program)",
      "key": "10.1016/j.ajhg.2007.10.002_bib29",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1365-2141.2006.06007.x",
      "article-title": "The c.-1639G→A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients",
      "author": "Montes",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "journal-title": "Br. J. Haematol.",
      "key": "10.1016/j.ajhg.2007.10.002_bib30",
      "volume": "133",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.clpt.2005.11.011",
      "article-title": "Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements",
      "author": "Aquilante",
      "doi-asserted-by": "crossref",
      "first-page": "291",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2007.10.002_bib31",
      "volume": "79",
      "year": "2006"
    },
    {
      "DOI": "10.1007/BF02983247",
      "article-title": "Racial background is a determinant factor in the maintenance dosage of warfarin",
      "author": "Gan",
      "doi-asserted-by": "crossref",
      "first-page": "84",
      "journal-title": "Int. J. Hematol.",
      "key": "10.1016/j.ajhg.2007.10.002_bib32",
      "volume": "78",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.tibs.2004.04.004",
      "article-title": "Vitamin K epoxide reductase: Homology, active site and catalytic mechanism",
      "author": "Goodstadt",
      "doi-asserted-by": "crossref",
      "first-page": "289",
      "journal-title": "Trends Biochem. Sci.",
      "key": "10.1016/j.ajhg.2007.10.002_bib33",
      "volume": "29",
      "year": "2004"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0002929708000736"
    }
  },
  "score": 0,
  "short-container-title": [
    "The American Journal of Human Genetics"
  ],
  "source": "Crossref",
  "title": [
    "Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish Populations"
  ],
  "type": "journal-article",
  "volume": "82"
}